Soluble Siglec-9 combined with exercise ameliorates HFD-induced metabolic and depressive-like phenotypes with gut-brain axis changes

Clicks: 11
ID: 331435
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #147 of 151 articles by views in PNAS nexus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 151 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Long-term intake of a high-fat diet (HFD) induces gut microbiota dysbiosis associated with inflammation and is linked to metabolic abnormalities and depressive-like behaviors. The soluble form of sialic acid-binding Ig-like lectin-9 (s-Siglec-9) exhibits therapeutic effects against inflammatory diseases, and exercise is known to have antidepressant effects. However, the effects of s-Siglec-9 on HFD-induced depressive-like behaviors, alone or in combination with exercise, remain unclear. In this study, we investigated the therapeutic effects of s-Siglec-9 combined with exercise in mice with HFD-induced metabolic dysfunction. Mice were fed an HFD ad libitum for 8 weeks, and interventions were conducted during the final 4 weeks. The induction of the anti-inflammatory phenotype by s-Siglec-9 was also investigated using primary microglia. The results revealed significant suppression of depressive-like behaviors in the intervention groups compared with the group fed only the HFD, with the effect being greater in the s-Siglec-9 with exercise group. Histological analyses showed reduced microglial activation and astrogliosis in the hippocampus and hypothalamus, together with increased hippocampal neurogenesis. Gut microbiota analysis showed a decrease in inflammatory bacterial genera and an increase in short-chain fatty acid-producing bacterial genera in the intervention groups. In vitro, s-Siglec-9 promoted a shift in primary microglia toward an anti-inflammatory and neurotrophic M2-like state in the presence of monocyte chemoattractant protein-1 and chondroitin sulfate proteoglycans. Our study suggests the potential of combining administration of an anti-inflammatory substance with exercise as a therapeutic strategy for metabolic abnormalities accompanied by depressive-like behaviors, potentially involving coordinated changes across gut microbiota, inflammatory, and neural systems.
Reference Key
openalex_W7220703313 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kohki Matsubara, Setsuro Tsukada, Shinnosuke Koketsu, Kazuto Ishida, Akihito Yamamoto, Yoshino Ueki
Are you one of these authors? Claim your profile
Journal PNAS nexus
Year 2026
DOI
10.1093/pnasnexus/pgag340
URL
https://doi.org/10.1093/pnasnexus/pgag340
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.